证券记录 · 已归档季度
TSHA
Taysha Gene Therapies, Inc. · Healthcare · Biotechnology
18被追踪持有人
-1Δ持有人
108.64M持有股份
$355.25M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -5.3% ·
股份流向 +9.6% ·
净新建仓位 -5.6%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +6 | 146.63M | $997.83M | +12 | −5 |
| Q1 2026 | 81 | -9 | 130.93M | $584.01M | +4 | −14 |
| Q4 2025 | 90 | 0 | 135.71M | $746.41M | +2 | −1 |
| Q3 2025 | 18 | -1 | 108.64M | $355.25M | — | −1 |
| Q2 2025 | 16 | +5 | 65.80M | $152.01M | +5 | — |
| Q1 2025 | 8 | -4 | 14.26M | $19.83M | +1 | −5 |
| Q4 2024 | 12 | +5 | 19.11M | $33.06M | +5 | — |
| Q3 2024 | 6 | 0 | 7.50M | $15.08M | +2 | −2 |
| Q2 2024 | 6 | — | 5.37M | $12.04M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 19.31M | — | $63.14M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 19.31M | — | $63.14M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 19.31M | — | $63.14M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 19.31M | — | $63.14M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 19.31M | — | $63.14M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 19.31M | — | $63.14M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 19.31M | — | $63.14M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 16.36M | +23.0% | $53.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 16.36M | +23.0% | $53.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 16.36M | +23.0% | $53.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 16.36M | +23.0% | $53.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 16.36M | +23.0% | $53.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 16.36M | +23.0% | $53.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 16.36M | +23.0% | $53.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 16.36M | +23.0% | $53.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 14.59M | -6.6% | $47.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Fidelity (FMR) ✦ | 14.59M | -6.6% | $47.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Fidelity (FMR) ✦ | 14.59M | -6.6% | $47.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Goldman Sachs Group ✦ | 13.38M | — | $43.76M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Goldman Sachs Group ✦ | 13.38M | — | $43.76M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (被动) | 12.85M | +17.9% | $42.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | The Vanguard Group ✦ (被动) | 12.85M | +17.9% | $42.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | The Vanguard Group ✦ (被动) | 12.85M | +17.9% | $42.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Point72 Asset Management ✦ | 7.33M | +0.2% | $23.97M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (被动) | 7.24M | +40.8% | $23.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | Geode Capital Management ✦ (被动) | 5.17M | +36.4% | $16.92M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Geode Capital Management ✦ (被动) | 5.17M | +36.4% | $16.92M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 28 | Millennium Management ✦ | 4.03M | +37.1% | $13.17M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 29 | Adage Capital Partners ✦ | 3.33M | -31.2% | $10.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 2.71M | +574.1% | $8.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 592.49K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 592.49K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 592.49K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 592.49K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 592.49K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 592.49K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Wellington Management ✦ | 568.01K | -10.7% | $1.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 568.01K | -10.7% | $1.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 568.01K | -10.7% | $1.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Marshall Wace ✦ | 476.87K | +499.9% | $1.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | Citadel Advisors ✦ | 367.31K | -30.6% | $1.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 42 | Citadel Advisors ✦ | 367.31K | -30.6% | $1.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 151.00K | +11.2% | $493,769 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 151.00K | +11.2% | $493,769 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 151.00K | +11.2% | $493,769 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 151.00K | +11.2% | $493,769 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | T. Rowe Price ✦ | 113.83K | +34.5% | $373,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 48 | Two Sigma Investments ✦ | 66.11K | +102.3% | $216,163 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Renaissance Technologies | $126,819 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 190 持有人, 265.00M 股份, $1.21B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据